HRMY HARMONY BIOSCIENCES HOLDINGS INC Management Changes 8-K Filing 2025 - Management Changes On March 24, 2025, Harmony Biosciences announced the departure of Chief Commercial Officer Jeffrey Dierks effective March 31, 2025, and appointed Adam Zaeske as his replacement, effective the same date; Dierks will receive $476,215 and accelerated vesting of stock options as part of his separation agreement dated March 20, 2025.Get access to all SEC 8-K filings of the HARMONY BIOSCIENCES HOLDINGS INC